C
Curaxon develops small‑molecule therapies for central nervous system disorders with high unmet medical need. The company modifies existing compounds to create drugs that have novel pharmacokinetic and pharmacodynamic profiles and enhanced efficacy. Its pipeline focuses on neurodegenerative and lysosomal storage diseases, aiming to improve patient outcomes.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Curaxon develops small‑molecule therapies for central nervous system disorders with high unmet medical need. The company modifies existing compounds to create drugs that have novel pharmacokinetic and pharmacodynamic profiles and enhanced efficacy. Its pipeline focuses on neurodegenerative and lysosomal storage diseases, aiming to improve patient outcomes.